Galectin Therapeutics, Inc. (GALT)

Galectin Therapeutics, Inc. (GALT) is focused on developing promising carbohydrate-based therapies for fibrotic liver disease and cancer leveraging its unique understanding of galectin proteins, key mediators of biologic function. Utilizing its team's extensive scientific and development expertise as well as established relationships with external sources, the company is able to achieve cost effective and efficient development.

Using unique carbohydrate-based candidate compounds that bind and inhibit galectin proteins, Galectin Therapeutics is pursuing therapies for indications where galectins have a demonstrated role in the pathogenesis of a particular disease. The company's efforts are directed to diseases with serious, life threatening consequences to patients, and those where current treatment options are limited.

Galectin Therapeutics' scientists have substantial expertise, developed over decades, in the area of carbohydrates that target Galectin receptors. Founder of the company Chief Scientist Dr. Klyosov, supplemented by members of the company's scientific and medical advisory boards, provides a substantial advantage in this relatively new area of drug development.

Recently, Galectin Therapeutics announced its new initiative to better understand the relationship of Galectin-3 to cardiac fibrosis in chronic cardiac arrhythmias. Galectin-3 is known to increase in patients with heart failure and is believed to be a critical mediator in the development of cardiac fibrosis. Understanding of these mechanisms could lead to new therapeutic approaches, including galectin inhibition, to cardiac fibrosis and chronic arrhythmias.

Legend Oil and Gas Ltd. (LOGL)

Legend Oil and Gas Ltd., an oil and gas production and exploration company, leverages the dual strategy of developing its existing oil producing assets, while actively seeking projects with significant "Blue Sky" potential in the oil-prone shale plays in southeastern Kansas, northern North Dakota and Canada. To set the foundation for its future growth, Legend acquired the Piqua project in 2010.

The Piqua property, a 1,040-acre site with 33 active wells in Woodson County, Kansas, has significant new drilling potential and is believed to have unrealized economic value. Legend plans to drill development wells and remediate any existing wells that require work on the site, as well as improve the production systems in place to potentially double production and create strong cash flow.

The company is led by a management team that is experienced in taking oil companies from the start-up and early development phases through the period of reserves and capital growth. Having accumulated extensive experience in senior management positions with several successful small- and medium-sized producers, the team brings over 60 years of combined oil industry experience to Legend.

In recent news, Legend Oil and Gas announced that it has signed a letter of intent (LOI) with International Sovereign Energy Corp. of Calgary, Alberta, Canada, to acquire all of its interests in land and production in Canada for a purchase price valued at $17.0 million. The purchase represents a combination of operated and non-operated oil and gas production properties as well as a large number of undeveloped leases.

Scorpex, Inc. (SRPX)

Scorpex, Inc. is focused on becoming a leader of hazardous and toxic waste disposal in the Baja Mexico/California region where demand for waste management exceeds capacity. To date, the company has constructed a 10,000 square foot storage facility, water reservoir and septic system, sprinkler system, and security fence and is in the process of developing other necessary infrastructure on its 26-acre site.

Joseph Caywood is the founder of Scorpex International and has developed the project for several years. His efforts have included overseeing construction, land acquisition, site development, permit applications, governmental relations, and submitting focused studies and reports by experts in this industry. As a result of his efforts, Scorpex will have the only industrial waste processing facility of its kind in Baja Mexico.

The Mexican economy has experienced significant growth in the manufacturing sector over the past several years. This growth has been fuelled by the NAFTA treaty and investments from foreign national companies. The growth of both new and existing industries has dramatically increased the need for the disposal of industrial waste throughout Mexico, especially in the Baja California region.

The company's future expansion plans include constructing other strategically placed, specially designed, storage, recycling and disposal facilities in various locations throughout Mexico. All facilities will be designed specifically for the purpose of processing the nation's growing industrial waste, including materials that are classified as industrial, toxic, and hazardous.

Last week, Scorpex announced it has entered into a $30 million equipment contract signed with International Environmental Technologies, Inc. ("IET") for the acquisition and installation of waste gasification/thermal oxidation equipment as well as a license to use the technology. IET's patented technology is capable of processing municipal waste, medical waste and hazardous waste simultaneously without presorting for maximum efficiency. The oxygen starved system virtually eliminates noise and noxious odors when operating while reducing waste volume by 95%.

Chief Executive Officer Joseph Caywood commented, "As I said previously, we have made remarkable progress and are very excited to be moving forward so quickly with our business strategy. Signing such a major equipment contract at the dawn of establishing our first waste disposal and processing plant is yet another strong vote of confidence by others who have chosen to join our initiative to address Mexico's growing demand for industrial, hazardous and toxic waste management."